Financials
- Market Capitalization 149.64 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.equilliumbio.com
- Headquarter Delaware, United States
- FIGI BBG00LSL8C10
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.97
Fiyat/satışlar oranı
220.4
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3754 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.34 USD | -2.91% | -7.45% | +7.23% | -17.97% | 148.75 M USD | ||
| 3755 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | -10.16% | -34.66% | -39.47% | 153.23 M USD | ||
| 3778 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.15 USD | -3.36% | +9.52% | +2.68% | -37.16% | 143.17 M USD | ||
| 3783 | ADCT ADC Therapeutics SA Common Shares | 1.13 USD | +0.89% | +14.14% | +1.80% | -65.23% | 144.26 M USD |